50-155-7066

MCM2 Polyclonal Antibody, Bethyl Laboratories

Manufacturer: Bethyl Laboratories, Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-155-7066-Each-of-1 In Stock ₹ 12,384.35

50-155-7066 - Each of 1

₹ 12,384.35

In Stock

Quantity

1

Base Price: ₹ 12,384.35

GST (18%): ₹ 2,229.183

Total Price: ₹ 14,613.533

Antigen

MCM2

Classification

Polyclonal

Formulation

TBS with 0.1% BSA and 0.09% sodium azide

Gene Accession No.

P49736, P97310

Gene Symbols

Mcm2

Immunogen

Between 1 and 50

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Applications

Immunohistochemistry, Western Blot

Conjugate

Unconjugated

Gene

MCM2

Gene Alias

minichromosome maintece complex component 2

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

17216, 4171

Content And Storage

4° C

Form

Liquid

Related Products

Img

Bethyl Laboratories, Inc

50-155-6941

--

Img

Bethyl Laboratories, Inc

50-155-6929

--

Img

Bethyl Laboratories, Inc

50-155-6939

--

Img

Bethyl Laboratories, Inc

50-155-7699

--

Img

Bethyl Laboratories, Inc

50-155-7877

--

Img

Bethyl Laboratories, Inc

50-155-6761

--

Img

Bethyl Laboratories, Inc

50-155-7412

--

Img

Bethyl Laboratories, Inc

50-155-7632

--

Description

  • The recommended shelf life for this product is 1 year from date of receipt
  • Application Note: For IHC, epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections
  • MCM2 (Mini chromosome maintece protein 2) is involved in regulating DNA replication
  • MCM2 (also called CDCL1, mitotin and BM28), is a human nuclear protein that is crucial in the cell cycle, being involved in the onset of DNA replication and cell division
  • It is similar to members of the family of early S-phase proteins
  • Mincheva et al
  • (1994) mapped the gene to 3q21
  • From its localization, CDCL1 became a candidate for an oncogene affected by chromosomal breaks in acute myeloid leukemia (AML).